<DOC>
	<DOCNO>NCT02600559</DOCNO>
	<brief_summary>This 8-week , multicenter , open-label study eligible subject history otitis medium require TT placement receive 6 mg OTO-201 ear . The study design evaluate safety efficacy OTO-201 subject undergo TT placement common concurrent surgery middle ear effusion status .</brief_summary>
	<brief_title>Open-Label Study OTO-201 Pediatric Subjects With History Otitis Media Requiring Tympanostomy Tubes</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<criteria>Inclusion Criteria include , limited : Subject male female age 6 month 17 year , inclusive Subject history otitis medium require bilateral tympanostomy tube placement Subject 's caregiver willing comply protocol attend study visit Exclusion Criteria include , limited : Subject history prior ear mastoid surgery , include myringotomy myringotomy TT placement Subject designate surgical procedure would occur concurrently TT placement , except adenoidectomy , airway endoscopy , nasal endoscopy , nasal cautery epistaxis Subject history sensorineural hearing loss</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Otitis medium</keyword>
	<keyword>Ear infection</keyword>
	<keyword>Tympanostomy tube</keyword>
</DOC>